Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
- PMID: 18490191
- DOI: 10.1016/j.oraloncology.2008.03.015
Erythropoietin administration during radiotherapy in anaemic head-and-neck cancer patients: is it still a reasonable option or too dangerous?
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
